Symbiotec Pharmalab DRHP & RHP
MainboardListedUpdated · GMP, subscription and listing data refresh through the day.
Symbiotec Pharmalab IPO Details
Symbiotec Pharmalab Financials ₹ in crore
| ₹ crore | 2024 | 2025 | 2026 |
|---|---|---|---|
| Revenue | ₹716.25 | ₹751.55 | ₹869.15 |
| Expenses | — | — | — |
| Net profit (PAT) | ₹100.06 | ₹96.79 | ₹109.9 |
| PAT margin | 14.0% | 12.9% | 12.6% |
| Total assets | ₹1,294.79 | ₹1,579.65 | ₹1,780.79 |
Symbiotec Pharmalab Shareholding before & after the IPO
This issue’s prospectus doesn’t state the post-issue register, and the exchange pattern is only filed around listing.
The founding owners and their group entities.
Pre-issue register from the RHP capital structure, cross-checked against exchange data. Pre-issue percentages are taken from the disclosure, never estimated.
Symbiotec Pharmalab IPO Lot Size & Minimum Investment by investor category
| Application | Shares | Amount at ₹988 |
|---|---|---|
| Retail (min)1 lot | 15 | ₹14,820 |
| Retail (max)13 lots | 195 | ₹1,92,660 |
| sHNI (min)14 lots | 210 | ₹2,07,480 |
| bHNI (min)68 lots | 1,020 | ₹10,07,760 |
One lot is 15 shares, so a single application at the ₹988 cut-off costs ₹14,820. Retail applications are capped at ₹2,00,000, which is 13 lots for this issue. Amounts are shown at the upper band because applications are made at the cut-off price.
Symbiotec Pharmalab DRHP & RHP offer documents
The draft red herring prospectus is filed with SEBI before the issue; the red herring prospectus adds the price band and dates just before bidding opens. Both describe the business, the restated financials, the risk factors and how the proceeds will be used.
Symbiotec Pharmalab IPO Strengths & Risks as disclosed in the DRHP
Strengths and risk factors from this issue’s prospectus aren’t available yet.
How to check Symbiotec Pharmalab IPO allotment status
Allotment is decided and published by the issue’s registrar, not by the exchange and not by alphave. For Symbiotec Pharmalab Limited, the registrar is MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) — allotment is finalised in the days between the issue closing on 27 Aug 2026 and listing on 01 Sept 2026.
Allotment and refund dates follow SEBI’s T+3 listing timeline in trading days and are tentative until the registrar and the exchange confirm them. alphave does not hold allotment results — only the registrar can show whether an application was allotted.
The registrar publishes allotment on its own portal: MUFG Intime. Your bank will also show the blocked amount released if shares were not allotted.
Symbiotec Pharmalab DRHP & RHP FAQs
Where can I read the Symbiotec Pharmalab DRHP or RHP?
The offer document for the Symbiotec Pharmalab Limited IPO is linked on this page as filed with the exchange; SEBI and the lead managers also host it.
What is a DRHP?
The Draft Red Herring Prospectus is the document a company files with SEBI before an IPO. It describes the business, the financials, the risk factors, the promoters and how the money raised will be used. The Red Herring Prospectus (RHP) is the version filed just before the issue opens, with the price band and dates added.
Symbiotec Pharmalab IPO Registrar where allotment and refund queries go
The registrar processes the allotment and the refunds. Contact details are as printed in the offer document; the exchange and your broker cannot change an allotment.
How to Apply for the Symbiotec Pharmalab IPO ASBA and UPI, as SEBI sets them
- Apply through your broker’s IPO window or your bank’s net banking (ASBA). The money stays in your own account and is only blocked until allotment.
- Choose the number of lots and bid at the cut-off price. Retail applications are capped at ₹2,00,000; above that the bid moves to the non-institutional category.
- If you applied through a broker, approve the UPI mandate in your payment app. The mandate must be approved by 5 pm on the day after your bid, and by 5 pm on the closing day for bids made on the last day (27 Aug 2026).
- One application per PAN. A second application under the same PAN is rejected, and both may be.
- After allotment the blocked amount is released for shares not allotted. Allotment and refund queries go to the registrar, MUFG Intime India Private Limited (Formerly Link Intime India Private Limited), not to the exchange or the broker.
What is GMP in an IPO?
Grey Market Premium is the price at which an unlisted IPO application or share changes hands informally, before the stock is listed on the exchange. It is quoted as a rupee figure over the issue price: a premium of ₹185 on a ₹988 upper band means the grey market is dealing at ₹1,173.
The grey market is an over-the-counter market between private dealers. It is not operated or supervised by NSE, BSE or SEBI, no trade is settled through a clearing corporation, and no dealer is obliged to publish or honour a quote. Figures are collected by third-party reporters and different sources routinely disagree, which is why a premium can move sharply within a day or vanish entirely once bidding closes.
Grey Market Premium is an unofficial, unregulated over-the-counter datapoint reported by third parties. It is not a price, a forecast, or an indication of listing gains, and is not investment advice.